RFA
PRAH

Reilly Financial Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Reilly Financial Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,982
Closed -$16.7M – 1107
2021
Q2 		$16.7M Sell
100,982
-19,302
-16% -$3.22M 1.35% 28
2021
Q1 		$18.4M Sell
120,284
-861
-0.7% -$117K 1.63% 18
2020
Q4 		$15.2M Buy
121,145
+1,353
+1% +$151K 1.42% 27
2020
Q3 		$12.2M Buy
119,792
+2,864
+2% +$292K 1.3% 31
2020
Q2 		$11.4M Buy
116,928
+2,284
+2% +$213K 1.34% 34
2020
Q1 		$9.52M Buy
114,644
+3,083
+3% +$301K 1.38% 31
2019
Q4 		$12.4M Buy
111,561
+23,605
+27% +$2.43M 1.41% 28
2019
Q3 		$8.73M Buy
+87,956
New +$8.73M 1.07% 50
2018
Q4 		– Sell
-100
Closed -$11K – 1051
2018
Q3 		$11K Buy
+100
New +$10.4K ﹤0.01% 682

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Reilly Financial Advisors's PRAH Position: Q3 2021 in Review

Reilly Financial Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 100,982 shares — an estimated $16.7M sold.

Reilly Financial Advisors first reported a position in PRAH in Q3 2018 and held it in 9 quarters. The position peaked at $18.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Reilly Financial Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Reilly Financial Advisors sold 100,982 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $16.7M.
  • Reilly Financial Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 9 quarters.
  • Reilly Financial Advisors's PRA Health Sciences, Inc. position peaked at $18.4M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Reilly Financial Advisors's 13F filing for Q3 2021, filed 19 Oct 2021.